Data / Form D filings / Grid Therapeutics LLC
Grid Therapeutics LLC: Form D filings
Grid Therapeutics LLC, a biotechnology company in Durham, NC, filed 3 Form D notices with the SEC between 2018 and 2023. The latest, on January 5, 2023, reports $1.7 million sold of a $1.7 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- THE IMPERIAL BUILDING, 215 MORRIS ST, SUITE 300, Durham, NC, 27701
- Phone
- (919) 987-7190
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1682338
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | New notice | $1,740,000 | $1,740,000 | 11 | Nov 19, 2022 | sec.gov | |
| Dec 9, 2020 | New notice | $5,000,000 | $1,909,367 | $3,090,633 | 7 | Nov 12, 2020 | sec.gov |
| Mar 29, 2018 | New notice | $5,000,000 | $4,540,451 | $459,549 | 12 | Mar 15, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kevin F. Schulman | Director | |
| Thomas F. Patz | Executive Officer, Director | |
| Edward F. Patz, Jr. | Executive Officer, Director, Promoter | |
| Scott F. Lyman | Executive Officer | |
| Paolo F. Paoletti | Director | |
| Richard F. Parker | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Jan 2, 2023 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Grid Therapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.